Voice-of-Customer Research

Unbiased. Unfiltered. If you want to know what your current or potential customers think, and what motivates their behavior, then you’ve come to right place. No one gets more comprehensive and nuanced information from real-world life science stakeholders than we do. Period.

Our Experts

Miguel Edwards

David Cavanaugh

David Cavanaugh

Carl Schoellhammer

Carl Schoellhammer

Schedule a Call

Related Client Results

All Client Results

Pharma & Biotech

Healthcare IT Solution Market Opportunity

A leading pharmaceutical & clinical diagnostics manufacturer wanted to understand the market opportunity for a novel multidisciplinary cancer conference IT support solution

Voice-of-Customer Research

Go-to-Market Strategy

Competitive Analysis

Clinical Diagnostics

NIPT Market Landscape and Strategy

A large multi-national diagnostic company was interested in understanding the market landscape and potential strategy for the decentralization of NIPT in the U.S.

Voice-of-Customer Research

Competitive Analysis

Customer Segmentation

Go-to-Market Strategy

Clinical Diagnostics

Carrier Screening Landscape Assessment

A leading diagnostics player wanted an assessment of the current and future carrier screening landscape, primarily in the U.S., to guide their product development strategy

Voice-of-Customer Research

Cell Line Market 5-Year Forecast

A large life science tools provider was interested in characterizing the genome engineering and engineered cell line market to identify potential opportunities to participate in the space

Voice-of-Customer Research

Clinical Diagnostics

Diagnostic Advisory Board

A diagnostics company requested DeciBio to help an advisory board (ad board) to understand how to position its relatively new somatic oncology genomics profiling product in an already competitive market

Voice-of-Customer Research

KOL Identification

Pharma & Biotech

Global Companion Diagnostic Guideline Mapping and Strategy

A large pharma new to precision oncology wanted to understand the processes and requirements to ensure that their novel CDx was included into diagnostic guidelines globally

Biomarker and Diagnostics Strategy

Go-to-Market Strategy

Precision Medicine is evolving at a rapid pace

Discover how we can help